Allogeneic Hematopoietic Stem Cell Transplant for People With Primary Immunodeficiency Diseases
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immunodeficiency Diseases A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immunode ...
Lymphoproliferative Disorders;Autoimmune Lymphoproliferative;Immune System Diseases;Common Variable Immunodeficiency;Primary T-cell Immunodeficiency Disorders Lymphoproliferative Disorders;Autoimmune Lymphoproliferative;Immune System Diseases;Common Variable ...
A phase I/II Study evaluating the safety and the efficacy of Human T Lymphoid Progenitor (HTLP) injection to accelerate immune reconstitution after partially HLA compatible allogeneic hematopoietic stem cell transplantation in SCID patients - HTLP NECKER A phase I/II Study evaluating the safety and the efficacy of Human T Lymphoid Progenitor (HTLP) inje ...
SCID pediatric patients (n=12 for analysis) requiring an HLA partially compatible allogeneic HSCT. MedDRA version: 20.0;Level: PT;Classification code 10010099;Term: Combined immunodeficiency;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Immune System Diseases [C20] SCID pediatric patients (n=12 for analysis) requiring an HLA partially compatible allogeneic HSCT. M ...